Jacobs Levy Equity Management’s Gossamer Bio GOSS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$557K	Sell	1,695,159 -482,874	-22%	-$759K	﹤0.01%	806
2025 Q4	$6.75M	Buy	2,178,033 +769,915	+55%	+$2.2M	0.03%	352
2025 Q3	$3.7M	Buy	1,408,118 +316,554	+29%	+$698K	0.01%	481
2025 Q2	$1.34M	Buy	1,091,564 +809,300	+287%	+$883K	0.01%	699
2025 Q1	$310K	Sell	282,264 -1,252,404	-82%	-$1.45M	﹤0.01%	974
2024 Q4	$1.39M	Sell	1,534,668 -352,844	-19%	-$302K	﹤0.01%	661
2024 Q3	$1.86M	Buy	1,887,512 +442,895	+31%	+$426K	0.01%	620
2024 Q2	$1.3M	Sell	1,444,617 -189,467	-12%	-$142K	0.01%	677
2024 Q1	$1.93M	Sell	1,634,084 -468,964	-22%	-$516K	0.01%	604
2023 Q4	$1.92M	Buy	+2,103,048	New	+$1.55M	0.01%	610
2022 Q2	–	Sell	-612,496	Closed	-$5.32M	–	1034
2022 Q1	$5.32M	Sell	612,496 -295,936	-33%	-$2.85M	0.04%	405
2021 Q4	$10.3M	Sell	908,432 -68,931	-7%	-$819K	0.07%	298
2021 Q3	$12.3M	Sell	977,363 -29,116	-3%	-$268K	0.08%	261
2021 Q2	$8.17M	Sell	1,006,479 -54,075	-5%	-$469K	0.06%	337
2021 Q1	$9.81M	Buy	1,060,554 +429,272	+68%	+$4.33M	0.08%	297
2020 Q4	$6.1M	Sell	631,282 -15,131	-2%	-$149K	0.05%	362
2020 Q3	$8.02M	Buy	646,413 +383,635	+146%	+$5.09M	0.08%	254
2020 Q2	$3.42M	Buy	262,778 +170,045	+183%	+$2.14M	0.04%	422
2020 Q1	$941K	Buy	92,733 +11,468	+14%	+$150K	0.01%	639
2019 Q4	$1.27M	Buy	+81,265	New	+$1.64M	0.01%	639